Literature DB >> 8930605

A radioimmunoassay for African catfish growth hormone: validation and effects of substances modulating the release of growth hormone.

O Lescroart1, I Roelants, T Mikolajczyk, P T Bosma, R W Schulz, E R Kühn, F Ollevier.   

Abstract

A highly sensitive radioimmunoassay has been developed for measuring plasma growth hormone (GH) concentrations in the African catfish (Clarias gariepinus). The lower detection limit of the assay was 0.1 ng/ml and the standard curve had an ED50 value of 0.5 ng/ml. The validity of the assay was established and the effects of several neurotransmitters on the release of GH were examined. In vitro experiments, using a static culture system for dispersed pituitary cells, demonstrated that the GH release in African catfish was affected by growth hormone-releasing hormone and somatostatin. Single intraperitoneal injections with a dopamine agonist, apomorphine, produced significant and dose-dependent increases in plasma GH levels. Unlike carp, goldfish, and tilapia, a super-active analogue of salmon gonadotrophin-releasing hormone did not alter plasma GH levels in African catfish.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930605     DOI: 10.1006/gcen.1996.0157

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  3 in total

1.  Immunological and physiological validation of enzyme-linked immunosorbent assay for growth hormone of the Asian catfish, Clarias batrachus.

Authors:  B Lal; A K Singh
Journal:  Fish Physiol Biochem       Date:  2005-04       Impact factor: 2.794

2.  Seasonal Related Multifactorial Control of Pituitary Gonadotropin and Growth Hormone in Female Goldfish: Influences of Neuropeptides and Thyroid Hormone.

Authors:  Yifei Ma; Claudia Ladisa; John P Chang; Hamid R Habibi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-07       Impact factor: 5.555

Review 3.  A Comparative Update on the Neuroendocrine Regulation of Growth Hormone in Vertebrates.

Authors:  Emilio J Vélez; Suraj Unniappan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-23       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.